Literature DB >> 15699137

Distinct effects of TGF-beta 1 on CD4+ and CD8+ T cell survival, division, and IL-2 production: a role for T cell intrinsic Smad3.

Susan C McKarns1, Ronald H Schwartz.   

Abstract

TGF-beta1 is critical for maintaining T cell homeostasis. Smad3 has been implicated in this regulatory process, yet the cellular targets and molecular details remain poorly understood. In this study, we report that TGF-beta1 impairs the entry of CD4+ and CD8+ T cells into the cell cycle as well as their progression through subsequent rounds of division, and show that Smad3 is essential for TGF-beta1 to inhibit TCR-induced division of only CD4+ and not CD8+ T cells. Both CD8+ and CD4+ T cells from Smad3-/- mice were refractory to TGF-beta1-induced inhibition of IL-2 production, thus demonstrating that not all CD8+ T cell responses to TGF-beta1 are Smad3 independent. These TGF-beta1 effects were all T cell intrinsic, as they were reproduced in purified CD4+ and CD8+ T cells. Finally, we found that Smad3 was critical for the survival of CD8+, but not CD4+ T cells following activation ex vivo. The TCR-induced death of Smad3-/- CD8+ T cells was not dependent upon TNF-alpha production. Exogenous TGF-beta1 partially rescued the CD8+ T cells by signaling through a Smad3-independent pathway. TGF-beta1 also enhanced survival of TCR-stimulated CD4+CD44high T cells in a Smad3-independent manner. Collectively, these findings firmly establish for the first time that TGF-beta1 discriminately regulates CD4+ and CD8+ T cell expansion by signaling through distinct intracellular pathways.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15699137     DOI: 10.4049/jimmunol.174.4.2071

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  42 in total

Review 1.  Immunoregulation of fetal and anti-paternal immune responses.

Authors:  Matthew M Seavey; Tim R Mosmann
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

2.  TRAF6 inhibits Th17 differentiation and TGF-beta-mediated suppression of IL-2.

Authors:  Pedro J Cejas; Matthew C Walsh; Erika L Pearce; Daehee Han; Gretchen M Harms; David Artis; Laurence A Turka; Yongwon Choi
Journal:  Blood       Date:  2010-03-29       Impact factor: 22.113

Review 3.  Negative regulators in homeostasis of naïve peripheral T cells.

Authors:  Jaime F Modiano; Lisa D S Johnson; Donald Bellgrau
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 4.  TGFβ in T cell biology and tumor immunity: Angel or devil?

Authors:  Eric Tu; Pei Zhi Cheryl Chia; Wanjun Chen
Journal:  Cytokine Growth Factor Rev       Date:  2014-07-29       Impact factor: 7.638

5.  Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model.

Authors:  Katherine A Waugh; Sonia M Leach; Brandon L Moore; Tullia C Bruno; Jonathan D Buhrman; Jill E Slansky
Journal:  J Immunol       Date:  2016-07-01       Impact factor: 5.422

6.  STAT3 signaling in CD4+ T cells is critical for the pathogenesis of chronic sclerodermatous graft-versus-host disease in a murine model.

Authors:  Vedran Radojcic; Maria A Pletneva; Hung-Rong Yen; Sanja Ivcevic; Angela Panoskaltsis-Mortari; Anita C Gilliam; Charles G Drake; Bruce R Blazar; Leo Luznik
Journal:  J Immunol       Date:  2009-12-07       Impact factor: 5.422

7.  CTLA4Ig inhibits effector T cells through regulatory T cells and TGF-β.

Authors:  Christine M Deppong; Traci L Bricker; Brandy D Rannals; Nico Van Rooijen; Chyi-Song Hsieh; Jonathan M Green
Journal:  J Immunol       Date:  2013-08-16       Impact factor: 5.422

Review 8.  Regulation of the Immune Response by TGF-β: From Conception to Autoimmunity and Infection.

Authors:  Shomyseh Sanjabi; Soyoung A Oh; Ming O Li
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-06-01       Impact factor: 10.005

9.  Diversity and plasticity of Th cell types predicted from regulatory network modelling.

Authors:  Aurélien Naldi; Jorge Carneiro; Claudine Chaouiya; Denis Thieffry
Journal:  PLoS Comput Biol       Date:  2010-09-02       Impact factor: 4.475

10.  TGFβ1-Mediated SMAD3 Enhances PD-1 Expression on Antigen-Specific T Cells in Cancer.

Authors:  Benjamin V Park; Zachary T Freeman; Ali Ghasemzadeh; Michael A Chattergoon; Alleluiah Rutebemberwa; Jordana Steigner; Matthew E Winter; Thanh V Huynh; Suzanne M Sebald; Se-Jin Lee; Fan Pan; Drew M Pardoll; Andrea L Cox
Journal:  Cancer Discov       Date:  2016-09-28       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.